ACT Brief: Wearable Data Integration Challenges, Human Performance Science, and Rare Disease Regulatory Flexibility

This is the Applied Clinical Trials Brief—your fast track to the latest insights shaping clinical operations and drug development.

• In part three of his video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, addressed challenges in integrating wearable data into clinical workflows. High-velocity continuous data from remote monitors creates information overload for providers managing large patient cohorts, and frequent false alarms lead clinicians to ignore potentially dangerous alerts.
• In a new ACT Academy session developed by Brian S. McGowan, PhD, Chief Learning Officer at ArcheMedX, the focus shifted to cognitive, learning, and behavioral science as drivers of clinical performance. Using spaced repetition and behavioral nudges, this approach builds true readiness and translates knowledge into consistent action under pressure, moving beyond compliance-driven training checkboxes.
• In a new interview from Pharmaceutical Executive, Laksheeta Johari, analyst for Lifescience Dynamics, discussed how FDA's Rare Disease Evidence Principles allow sponsors greater flexibility in trial design and control arms while maintaining safety as paramount. Recent CRLs suggest FDA application may diverge from stated guidance, creating uncertainty and signaling a need for better alignment across regulatory touchpoints.

That's all for today's ACT Brief. Join us next week for more updates shaping clinical operations and drug development. Thanks for listening.